| Name | Title | Contact Details |
|---|
Roby Institute CALM International Online Allergy Center is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization for both insured, and uninsured patients.
Royal Life Centers is an addiction treatment network with top-rated drug and alcohol detox and rehab centers. Our inpatient and outpatient programs are multi-accredited.
Lille Corp. is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.